Heather Davis, PhD

Jannsen

Heather has more than 25 years of experience in pharmaceutical drug development, mostly in vaccines and immune modulators to prevent or treat various diseases including hepatitis B and C. This experience was gained at Coley Pharmaceutical Group (which she co-founded), Pfizer Vaccine Division, Seqirus/CSL and now Janssen, a Johnson & Johnson company. Her current role at Janssen is VP, R&D Leader Hepatitis and she is located in Belgium. 

Prior to working in the pharmaceutical industry, Heather was a professor in academia, and held positions at McGill University (Montreal) and the University of Ottawa (Ottawa, Canada).